View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. Comment
January 28, 2022

Rise in Covid-19 cases causes medical device shortage

By GlobalData Healthcare

The Covid-19 pandemic has been ongoing for several years, and hospitals have faced many hardships as a result. At the beginning of the pandemic, hospitals and healthcare workers had to adapt to the new normal, hearing promises from government officials that things would get better soon. When the Covid-19 pandemic started, the world was unprepared. Hospitals hadn’t imagined that they would need so many masks, gloves, respirators and more. Very soon, they lacked the proper personal protective equipment (PPE) to keep them safe, and the general public did too, but by the third year of the pandemic, PPE should be readily available where needed.

Free Report
img

Medical Device Industry Landscape In Asia-Pacific

GlobalData's APAC Medical Devices Industry Landscape – 2022 free study breaks down the APAC medical devices market by segment and region and includes insights on local and global competitors, pipeline product developments, clinical trials studies, and significant deals in the industry. The APAC medical device industry witnessed significant developments, launches, implementations, and adoption of new medical device technologies in the past decade, however the high cost of devices, regulatory hurdles, reimbursement pressure, and healthcare budget constraints have challenged market expansion across various territories and segments. APAC is the fastest growing regional market for medical device clinical trials, with China and Japan emerging as major clinical trial hotspots. The growth in medical device clinical trials in the APAC region is attributed to an increase in research partnerships between biopharma companies and clinical research organizations (CROs). This report also provides an in-depth analysis of the medical device market's opportunities and challenges, the influence of COVID-19 on the market, and government activities aimed to develop the APAC medical device market.
by GlobalData
Enter your details here to receive your free Report.

The Omicron variant has spread rapidly, and cases are surging as a result. Many states and provinces are experiencing a shortage of N95 and KN95 masks, which are deemed the best masks to prevent the spread of Covid-19. In addition, rapid antigen tests are increasingly difficult to find in most provinces and many states. PCR tests are also hard to find in many provinces, often reserved for healthcare professionals or vulnerable populations.

In Canada, the government has distributed rapid antigen tests to the provinces, which are often given out at pop-up clinics. However, there are long line-ups to get the tests, and they are gone within minutes, which isn’t accessible for most. Some pharmacies sell the tests, but they are expensive and still hard to come by. The lack of testing available makes it difficult for people to know if they are positive for Covid-19 and can result in further spreading of the disease.

In addition to PPE and Covid-19 tests, there is now a shortage of all blood specimen collection tubes. The US Food and Drug Administration (FDA) has advised healthcare professionals to minimise the use of blood collection tubes. They have stated that healthcare professionals should only perform blood draws when medically necessary, and they should consider sharing samples between lab departments when possible.

The lack of PPE and, now, shortage of blood collection tubes shows that hospitals and other healthcare institutions still are not equipped to handle this pandemic. At this rate, there may be a shortage of other medical devices down the line, and the healthcare system could suffer further.

Related Companies

Free Report
img

Medical Device Industry Landscape In Asia-Pacific

GlobalData's APAC Medical Devices Industry Landscape – 2022 free study breaks down the APAC medical devices market by segment and region and includes insights on local and global competitors, pipeline product developments, clinical trials studies, and significant deals in the industry. The APAC medical device industry witnessed significant developments, launches, implementations, and adoption of new medical device technologies in the past decade, however the high cost of devices, regulatory hurdles, reimbursement pressure, and healthcare budget constraints have challenged market expansion across various territories and segments. APAC is the fastest growing regional market for medical device clinical trials, with China and Japan emerging as major clinical trial hotspots. The growth in medical device clinical trials in the APAC region is attributed to an increase in research partnerships between biopharma companies and clinical research organizations (CROs). This report also provides an in-depth analysis of the medical device market's opportunities and challenges, the influence of COVID-19 on the market, and government activities aimed to develop the APAC medical device market.
by GlobalData
Enter your details here to receive your free Report.

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Medical Device Network